World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
98
Citations
77727
World Ranking
767
National Ranking
436

Medicine

D-Index
98
Citations
77731
World Ranking
8720
National Ranking
4495

Overview

Richard S. Hotchkiss is affiliated with Washington University in St. Louis in the United States. Their research primarily focuses on medical and immunological sciences, particularly addressing critical issues related to infectious diseases and immune responses.

The scientist's recent publications span several vital topics in the area of sepsis and COVID-19, reflecting research interests in immune dysregulation and inflammatory processes. Notable papers include:

  • Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections, 2020, published in JCI Insight
  • Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm, 2020, Science Advances
  • Immunotherapies for COVID-19: lessons learned from sepsis, 2020, The Lancet Respiratory Medicine
  • Reframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapies, 2024, The Lancet Respiratory Medicine
  • COVID-19 disease and immune dysregulation, 2022, Best Practice & Research Clinical Haematology

Frequent coauthors collaborating with Richard S. Hotchkiss include Kenneth E. Remy, Monty B. Mazer, Lyle L. Moldawer, Scott C. Brakenridge, and Charles C. Caldwell. This network reflects a collaborative approach toward better understanding sepsis, immune responses, and COVID-19-related pathologies.

The main fields of study for the scientist are Medicine and Immunology and Microbiology. Subfields of significant publication output include infectious diseases, epidemiology, immunology, neurology, and critical care and intensive care medicine.

The research topics covered show a focus on clinical and immunological aspects, notably:

  • Sepsis Diagnosis and Treatment
  • COVID-19 Clinical Research Studies
  • Immune Response and Inflammation
  • SARS-CoV-2 and COVID-19 Research
  • Long-Term Effects of COVID-19
  • Adrenal Hormones and Disorders
  • Inflammation biomarkers and pathways

Richard S. Hotchkiss regularly publishes in venues such as Shock, JCI Insight, bioRxiv (Cold Spring Harbor Laboratory), Critical Care Explorations, and The Lancet Respiratory Medicine.

Best Publications

  • The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

    Mervyn Singer;Clifford S. Deutschman;Christopher Warren Seymour;Manu Shankar-Hari

  • The pathophysiology and treatment of sepsis.

    Richard S Hotchkiss;Irene E Karl

  • Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy

    Richard S. Hotchkiss;Guillaume Monneret;Didier Payen

  • Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure

    Jonathan S. Boomer;Kathleen To;Kathy C. Chang;Osamu Takasu

  • Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach

    Richard S Hotchkiss;Guillaume Monneret;Didier Payen

  • Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction

    Hotchkiss Rs;Swanson Pe;Freeman Bd;Tinsley Kw

  • Sepsis and septic shock

    Richard R.S. Hotchkiss;Lyle Linc Moldawer;Steven Opal;Konrad Reinhart

  • MECHANISMS OF DISEASE Cell Death

    Richard S. Hotchkiss;Andreas Strasser;Jonathan E. McDunn;Paul E. Swanson

  • Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans.

    Hotchkiss Rs;Tinsley Kw;Swanson Pe;Schmieg Re

  • Apoptosis and caspases regulate death and inflammation in sepsis

    Richard S. Hotchkiss;Donald W. Nicholson

  • Host-directed therapies for bacterial and viral infections

    Stefan H. E. Kaufmann;Anca Dorhoi;Richard S. Hotchkiss;Ralf Bartenschlager

  • A guiding map for inflammation

    Mihai G Netea;Frances Balkwill;Michel Chonchol;Fabio Cominelli

  • Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte.

    R. S. Hotchkiss;K. C. Chang;P. E. Swanson;K. W. Tinsley

  • The sepsis seesaw: tilting toward immunosuppression.

    Richard S Hotchkiss;Craig M Coopersmith;Jonathan E McDunn;Thomas A Ferguson

  • Prevention of lymphocyte cell death in sepsis improves survival in mice.

    R. S. Hotchkiss;K. W. Tinsley;P. E. Swanson;K. C. Chang

  • Mechanisms of Cardiac and Renal Dysfunction in Patients Dying of Sepsis

    Osamu Takasu;Joseph P. Gaut;Eizo Watanabe;Kathleen To

  • Depletion of Dendritic Cells, But Not Macrophages, in Patients with Sepsis

    Richard S. Hotchkiss;Kevin W. Tinsley;Paul E. Swanson;Mitchell H. Grayson

  • Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis.

    Richard S. Hotchkiss;Irene E. Karl

  • Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms

    Maya Saleh;John P. Vaillancourt;Rona K. Graham;Matthew Huyck

  • Persistent lymphopenia after diagnosis of sepsis predicts mortality.

    Anne M. Drewry;Navdeep Samra;Lee P. Skrupky;Brian M. Fuller

  • Overexpression of Bcl-2 in Transgenic Mice Decreases Apoptosis and Improves Survival in Sepsis

    Hotchkiss Rs;Swanson Pe;Knudson Cm;Chang Kc

Frequent Co-Authors

Paul E. Swanson
Paul E. Swanson University of Washington
W. Michael Dunne
W. Michael Dunne bioMérieux (France)
Robert H. Mach
Robert H. Mach University of Pennsylvania
Charles C. Caldwell
Charles C. Caldwell University of Cincinnati
Lyle L. Moldawer
Lyle L. Moldawer University of Florida
William G. Hawkins
William G. Hawkins Washington University in St. Louis
Joseph J. H. Ackerman
Joseph J. H. Ackerman Washington University in St. Louis
Thomas A. Ferguson
Thomas A. Ferguson Washington University in St. Louis
Marin H. Kollef
Marin H. Kollef Washington University in St. Louis
William C. Chapman
William C. Chapman Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their knowledge in Immunology, exploring related online degrees can open up diverse career pathways in healthcare and research. Many nursing professionals choose to specialize further by pursuing a Nurse Practitioner (NP) program. If you're considering this route, it’s helpful to know which programs are more accessible; for instance, this guide on what is the easiest np program can provide valuable insights.

Psychiatric Mental Health Nurse Practitioner (PMHNP) programs are another popular option, especially for those aiming to address mental health issues related to immunological conditions. Finding quality education with strong clinical opportunities is key. Check out this list of the top pmhnp programs known for excellent clinical placement rates.

For students mindful of tuition costs, affordable options do exist. This resource on the cheapest online pmhnp certificate programs highlights budget-friendly paths to certification without compromising quality.

Finally, understanding the financial outlook is crucial. Advanced degrees like a Doctor of Nursing Practice (DNP) significantly impact earning potential. Explore the dnp salary by specialty to see how different specializations, including immunology-related fields, compare across the U.S.

Best Scientists Citing Richard S. Hotchkiss

Trending Scientists